These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11484423)

  • 1. Detection time of drugs of abuse in urine.
    Vandevenne M; Vandenbussche H; Verstraete A
    Acta Clin Belg; 2000; 55(6):323-33. PubMed ID: 11484423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweat testing in opioid users with a sweat patch.
    Kintz P; Tracqui A; Mangin P; Edel Y
    J Anal Toxicol; 1996 Oct; 20(6):393-7. PubMed ID: 8889674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening.
    Mulé SJ; Casella GA
    J Anal Toxicol; 1988; 12(2):102-7. PubMed ID: 3379919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
    Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
    J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine.
    Kim SY; Kim H; Park Y; Lim J; Kim J; Koo SH; Kwon GC
    J Anal Toxicol; 2017 Jun; 41(5):412-420. PubMed ID: 28201761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin.
    Smith ML; Shimomura ET; Summers J; Paul BD; Jenkins AJ; Darwin WD; Cone EJ
    J Anal Toxicol; 2001 Oct; 25(7):504-14. PubMed ID: 11599592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
    Towt J; Tsai SC; Hernandez MR; Klimov AD; Kravec CV; Rouse SL; Subuhi HS; Twarowska B; Salamone SJ
    J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration.
    Smith ML; Shimomura ET; Summers J; Paul BD; Nichols D; Shippee R; Jenkins AJ; Darwin WD; Cone EJ
    J Anal Toxicol; 2000 Oct; 24(7):522-9. PubMed ID: 11043654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmatory tests for drugs in the workplace by gas chromatography-mass spectrometry.
    Goldberger BA; Cone EJ
    J Chromatogr A; 1994 Jul; 674(1-2):73-86. PubMed ID: 8075776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of drugs of abuse in exhaled breath from users following recovery from intoxication.
    Beck O; Stephanson N; Sandqvist S; Franck J
    J Anal Toxicol; 2012; 36(9):638-46. PubMed ID: 23045289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma.
    Jenkins AJ; Oyler JM; Cone EJ
    J Anal Toxicol; 1995 Oct; 19(6):359-74. PubMed ID: 8926729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
    Korte T; Pykäläinen J; Lillsunde P; Seppälä T
    J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment.
    Carlsson S; Olsson R; Lindkvist I; Beck O
    Scand J Clin Lab Invest; 2015 Apr; 75(2):156-61. PubMed ID: 25562730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of unconjugated morphine, codeine and 6-acetylmorphine in urine specimens from suspected drugged drivers.
    Ceder G; Jones AW
    J Forensic Sci; 2002 Mar; 47(2):366-8. PubMed ID: 11908609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing false-negative tests in urinary drugs-of-abuse screening.
    Luceri F; Godi F; Messeri G
    J Anal Toxicol; 1997; 21(3):244-5. PubMed ID: 9171214
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of urinary drugs of abuse by a multianalyte capillary electrophoretic immunoassay.
    Caslavska J; Allemann D; Thormann W
    J Chromatogr A; 1999 Apr; 838(1-2):197-211. PubMed ID: 10327639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of immunoassays for semiquantitative detection of cocaine and metabolites or heroin and metabolites in extracts of sweat patches.
    Moody DE; Cheever ML
    J Anal Toxicol; 2001 Apr; 25(3):190-7. PubMed ID: 11327351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excretion profile of opiates in dependent patients in relation to route of administration and type of drug measured in urine with immunoassay.
    Taracha E; Habrat B; Chmielewska K; Baran-Furga H
    J Anal Toxicol; 2005; 29(1):15-21. PubMed ID: 15808008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs of abuse screening in the West Midlands: a 6 year retrospective survey of results.
    George S; Braithwaite RA
    Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():473-8. PubMed ID: 7832574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.